The global veterinary biomarkers market size is expected to reach USD 2.6 billion by 2033 and is expected to grow at a CAGR of 12.1% from 2026 to 2033, according to a new report by Grand View Research, Inc. The key drivers for the market growth are the increasing prevalence of numerous acute and chronic disorders among animals coupled with the growing demand for better & accurate diagnostic and monitoring technologies. According to the American Veterinary Medical Association, almost half of the dog population is developing cancer at the same rate as humans. This supports the requirement for biomarker-based specific diagnostic kits for timely disease predictions and treatments.
The COVID-19 pandemic created barriers and challenges in the global animal health industry that include decreased marketing & sales activities, low veterinary clinic admission, cancellation of routine pet check-ups, and a low number of disease diagnostic tests performed in veterinary hospitals. However, governments and veterinary organizations of various countries implemented strategies and safety measures to resume veterinary practices and research during the pandemic. According to the American Veterinary Medical Association, telemedicine services were widely incorporated in veterinary clinics and hospitals to curb the impact of lockdowns. Furthermore, the pet parents were given digital training to use certain diagnostic kits.
The increasing animal care expenditure in both developing and developed economies is a significant opportunity for market growth. According to the American Kennel Club (AKC), pet owners in the U.S. were spending more money on their pet’s wellness and related healthcare products. The American Pet Products Association reported that the overall pet industry sale exceeded USD 140 billion by the end of 2022. In addition, the research and development activity in the upcoming fields, such as biomarkers in the veterinary, has been significantly growing over the last decade. These factors are expected to boost the growth of the market.
Request a free sample copy or view report summary: Veterinary Biomarkers Market Report
The companion animals segment dominated the industry with the highest revenue share of 59.8% in 2025.
The biomarkers, kits & reagents segment held the largest market share in 2025. This is owing to the wide availability of major brands of biomarkers and test kits launched by key players in the market.
The disease diagnostics segment held the largest market share in 2025.
The inflammatory & infectious diseases segment held the largest market share of 33.2% in 2025.
North America veterinary biomarkers market held a 33.0% share in 2025.
Grand View Research has segmented the global veterinary biomarkers market report based on animal, product, application, disease type, end use and region:
Veterinary Biomarkers Animal Outlook (Revenue, USD Million, 2021 - 2033)
Companion Animals
Dogs
Cats
Horses
Others
Production Animals
Cattle
Pigs
Poultry
Others
Veterinary Biomarkers Product Outlook (Revenue, USD Million, 2021 - 2033)
Biomarkers, Kits & Reagents
Instruments
Veterinary Biomarkers Application Outlook (Revenue, USD Million, 2021 - 2033)
Disease Diagnostics
Preclinical Research
Others
Veterinary Biomarkers Disease Type Outlook (Revenue, USD Million, 2021 - 2033)
Inflammatory & Infectious Diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Oncology
Others
Veterinary Biomarkers End Use Outlook (Revenue, USD Million, 2021 - 2033)
Veterinary Diagnostic Laboratories
Veterinary Hospitals & Clinics
Others
Veterinary Biomarkers Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
UAE
Saudi Arabia
Kuwait
Qatar
Oman
List of Key Players in the Veterinary Biomarkers Market
Zoetis
Virbac
Life Diagnostics
ACUVET BIOTECH
Merck
IDEXX Laboratories, Inc.
MI:RNA Diagnostics Ltd.
Mercodia AB
Antech Diagnostics, Inc.
Avacta Animal Health Limited
"The quality of research they have done for us has been excellent..."